Title
Category
Credits
Event date
Cost
- Disease management
- 0.75 ACPE - Pharmacists
- 0.75 ACPE - Pharmacy Technicians
- 0.75 AMA - Physicians
- 0.75 ANCC - Nurses
- 0.75 APA - Psychologists
- 0.75 Attendance - General Attendance
- 0.75 CDR - Dietitians
- 0.75 ASWB - Social Workers
$0.00
This session will provide participants with an in-depth understanding of the role of genetic testing in pediatric oncology, focusing on the use of germline and tumor genetic testing in diagnosing and treating pediatric cancers. It will explore the development and application of rare-disease specific drugs as models for targeted therapy and analyze the differences and similarities in cancer development between pediatric and adult patients, highlighting the implications for treatment strategies. Participants will also develop strategies for incorporating genetic testing and targeted therapies into routine clinical practice.
- Disease management
- 1.00 ACPE - Pharmacists
- 1.00 ACPE - Pharmacy Technicians
- 1.00 AMA - Physicians
- 1.00 ANCC - Nurses
- 1.00 APA - Psychologists
- 1.00 Attendance - General Attendance
- 1.00 CDR - Dietitians
- 1.00 ASWB - Social Workers
$0.00
This activity will delve into the genetic predispositions and environmental factors contributing to the formation of aortic aneurysms (AA) and how these insights are leading to personalized treatment strategies. It will focus on advancements in screening, diagnosis and treatment, including ongoing research into new therapies such as intravenous immune-modulating cells that can potentially reduce aneurysm size.
- Behavioral health
- Older adults
- 1.00 AMA - Physicians
- 1.00 ANCC - Nurses
- 1.00 APA - Psychologists
- 1.00 Attendance - General Attendance
- 1.00 CCMC - General - Case Managers
- 1.00 ASWB - Social Workers
$0.00
This activity will provide an overview of the role of resilience and PIL, examine characteristics associated with resilience and PIL and describe intervention strategies to promote resilience and successful aging in older adults.
- Disease management
- Rare diseases
- 0.50 ACPE - Pharmacists
- 0.50 ACPE - Pharmacy Technicians
- 0.50 AMA - Physicians
- 0.50 ANCC - Nurses
- 0.50 APA - Psychologists
- 0.50 Attendance - General Attendance
- 0.50 CCMC - General - Case Managers
- 0.50 ASWB - Social Workers
$0.00
This podcast will share insights and perspectives directly from Deborah Hecht, who is an individual with achondroplasia and a mother and grandmother of children with achondroplasia.
- Behavioral health
- Disease management
- Wellness
- 0.75 ACPE - Pharmacists
- 0.75 ACPE - Pharmacy Technicians
- 0.75 AMA - Physicians
- 0.75 ANCC - Nurses
- 0.75 APA - Psychologists
- 0.75 Attendance - General Attendance
- 0.75 CDR - Dietitians
- 0.75 ASWB - Social Workers
$0.00
This activity will outline racial and socioeconomic status disparities and provide examples of why they may exist among different populations, identify challenges associated with the diagnosis and management of obesity, including diagnostic accuracy, access to care, and impact on health care costs and quality of life and discuss potential interventions that can reduce obesity care inequities.
- Disease management
- Rare diseases
- 1.00 ACPE - Pharmacists
- 1.00 ACPE - Pharmacy Technicians
- 1.00 AMA - Physicians
- 1.00 ANCC - Nurses
- 1.00 APA - Psychologists
- 1.00 Attendance - General Attendance
- 1.00 CCMC - General - Case Managers
- 1.00 ASWB - Social Workers
$0.00
This activity will explore recent advances in the diagnosis and treatment of KLA and other lymphatic conditions, including current clinical trials. It will also share insights and perspectives from and provide strategies to support the well-being of both the individual and their family/caregiver(s).
- Disease management
- Rare diseases
- 0.75 ACPE - Pharmacists
- 0.75 ACPE - Pharmacy Technicians
- 0.75 AMA - Physicians
- 0.75 ANCC - Nurses
- 0.75 APA - Psychologists
- 0.75 Attendance - General Attendance
- 0.75 CCMC - General - Case Managers
- 0.75 ASWB - Social Workers
$0.00
This podcast will share insights and perspectives directly from Diane Bomberg and provide strategies that the interprofessional health care team can utilize to better support those impacted by rare diseases such as lymphangiomatosis.
- Disease management
- Rare diseases
- 1.00 ACPE - Pharmacists
- 1.00 ACPE - Pharmacy Technicians
- 1.00 AMA - Physicians
- 1.00 ANCC - Nurses
- 1.00 APA - Psychologists
- 1.00 Attendance - General Attendance
- 1.00 CCMC - General - Case Managers
- 1.00 ASWB - Social Workers
$0.00
This activity will explore the recent advances in the diagnosis and treatment of achondroplasia and other causes of disproportionate short stature. It will also share the importance of the interprofessional team to provide insights, perspectives and strategies to support the well-being of both the individual and their family/caregiver(s).
- Disease management
- Older adults
- 0.50 AMA - Physicians
- 0.50 ANCC - Nurses
- 0.50 Attendance - General Attendance
- 0.50 ASWB - Social Workers
$0.00
The process of advanced care planning (ACP) is widely recognized as a method to support patient self-determination, facilitate decision-making and promote better care. The responsibilities of the clinician are to utilize diagnostic tests, observe vital signs, diagnose illness, administer treatment, provide a prognosis based on treatment progress and document the patient's medical history. ACP will not succeed without effective communication between clinicians and patients, as well as family members and caregivers as appropriate. Existing barriers when engaging patients in ACP may be challenging for health care professionals. This activity will describe the role of the clinician in ACP, identify existing barriers and discuss how to overcome those barriers.
- Disease management
- Pharmacy benefit management
- 1.00 ACPE - Pharmacists
- 1.00 ACPE - Pharmacy Technicians
- 1.00 AMA - Physicians
- 1.00 ANCC - Nurses
- 1.00 Attendance - General Attendance
$0.00
This on-demand webcast is designed to equip primary care providers with the knowledge and skills necessary to effectively implement deprescribing practices. It will discuss the challenges of problematic polypharmacy and identify strategies for recognizing deprescribing opportunities, as well as describe the role of governance strategies in deprescribing initiatives. Deprescribing, the process of tapering or stopping medications that may no longer be beneficial or may be causing harm, is crucial for improving patient outcomes and enhancing quality of life.